Shivali Fulchand

ORCID: 0000-0003-2918-3931
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Skin and Cellular Biology Research
  • Innovations in Medical Education
  • Health and Medical Research Impacts
  • Primary Care and Health Outcomes
  • Diversity and Career in Medicine
  • Autoimmune Bullous Skin Diseases
  • Empathy and Medical Education
  • Dermatologic Treatments and Research
  • Medical Education and Admissions
  • Advances in Oncology and Radiotherapy
  • Hair Growth and Disorders
  • Public Health Policies and Education
  • Adolescent and Pediatric Healthcare
  • Climate Change and Health Impacts
  • Genetic factors in colorectal cancer
  • RNA regulation and disease
  • Medicine and Dermatology Studies History
  • Silk-based biomaterials and applications
  • Chronic Disease Management Strategies
  • Healthcare Systems and Challenges
  • Respiratory Support and Mechanisms
  • Autopsy Techniques and Outcomes
  • Clinical Reasoning and Diagnostic Skills
  • Long-Term Effects of COVID-19
  • Viral Infectious Diseases and Gene Expression in Insects

Stanford University
2021-2024

Cardiff University
2014-2023

BMJ Group (United Kingdom)
2019-2020

British Medical Association
2020

Kettering General Hospital
2018

University Hospitals of Leicester NHS Trust
2018

Cochrane
2014-2016

Abstract Background Recessive dystrophic epidermolysis bullosa (RDEB) is a rare, devastating blistering genodermatosis caused by mutations in the COL7A1 gene, which encodes for type VII collagen and necessary dermal-epidermal adhesion integrity. Disease manifestations include severe debilitating wounds, aggressive squamous cell carcinomas, premature death; however, there are currently no approved therapies. This Phase 1/2a, open-label study evaluated long-term efficacy safety of...

10.1186/s13023-022-02546-9 article EN cc-by Orphanet Journal of Rare Diseases 2022-10-17

Guideline: Diagnosis and management of cardiovascular disease during the covid-19 pandemic Published by European Society Cardiology. This summary is based on version published 21 April 2020 ( https://www.escardio.org/Education/COVID-19-and-Cardiology/ESC-COVID-19-Guidance )

10.1136/bmj.m1997 article EN BMJ 2020-05-20

Abstract Introduction Dystrophic epidermolysis bullosa is a debilitating skin condition, without curative treatment. Previous research has focused on the recessive variant, which known to cause severe disease. Limited work focusing clinical manifestations and outcomes of dominant dystrophic found (DDEB). Methods Analysis an online survey 42 DDEB patients. Results Self‐reported severity disease did not correlate with size wound or number dressing changes, but pain reported in last 12 months...

10.1111/pde.14802 article EN Pediatric Dermatology 2021-09-01

Epidermolysis bullosa simplex (EBS) comprises a group of rare, blistering genodermatoses. Prior work has been limited by small sample sizes, and much remains unexplored about the disease burden health-related quality life (QOL) patients with EBS. The aim this study was to characterize most common patient-reported clinical manifestations impact QOL in EBS, examine differences age.Patients diagnosis epidermolysis (EB) or their caregivers completed one-time online survey administered EBCare, an...

10.1186/s13023-022-02433-3 article EN cc-by Orphanet Journal of Rare Diseases 2022-07-15

AbstractPurpose Engagement in research and publication helps medical students develop the skills to improve healthcare through evidence-based medicine. The qualitative evidence-base for student experience of publishing is limited. This study aims explore students' practices understand their experiences publication.Methods based on a mixed-methods convergent design. A survey questionnaire was distributed UK schools by social media email communication. We recruited volunteer participants...

10.1080/0142159x.2023.2244661 article EN Medical Teacher 2023-09-30

Several doctors have been arrested for taking part in non-violent demonstrations Extinction Rebellion, finds Shivali Fulchand

10.1136/bmj.l6875 article EN BMJ 2019-12-13

Abstract Background: Recessive dystrophic epidermolysis bullosa (RDEB) is a rare, blistering genetic disease where wounding and wound pain are the most commonly reported problems by patients. The natural history of RDEB wounds has not been prospectively studied, thus limiting design clinical trial endpoints. Objective: To determine differences in spontaneous closure between chronic open vs recurrent wounds. Methods: We conducted prospective observational study which participants used mobile...

10.21203/rs.3.rs-3876810/v1 preprint EN cc-by Research Square (Research Square) 2024-03-26

The National Institute for Health and Care Excellence (NICE) has recommended in draft guidance that babies at risk of spina bifida be operated on the womb using an open repair technique specialised NHS centres by clinical teams with specific training experience.1 It concluded, however, there was not enough evidence to recommend prenatal keyhole advised this procedure should only used context research. NHS England said it would fund …

10.1136/bmj.l5769 article EN BMJ 2019-09-26

Only a small number of children with solid tumour cancers are able to access targeted precision medicine that is already available for adults, study has found. Researchers from the Institute Cancer Research and Royal Marsden NHS Foundation Trust in London set out evaluate whether their methods DNA analysis could inform clinical treatment young people tumours. Precision uses sequencing identify gene mutations cancer included long term plan try improve outcomes England. Precision specific...

10.1136/bmj.l5696 article EN BMJ 2019-09-24

From using a streetlight to study during his childhood in an industrial town India becoming president of the World Psychiatric Association, Dinesh Bhugra has led remarkable life. <b>Shivali Fulchand</b> talks him about journey

10.1136/bmj.m446 article EN BMJ 2020-02-11

Sharing data to prevent violence is a revelation that came Jonathan Shepherd 30 years ago—and now significantly cutting violent injuries worldwide, writes Shivali Fulchand

10.1136/bmj.m2987 article EN BMJ 2020-10-14
Coming Soon ...